Treatment of epithelial thymic tumours: Towards a multidisciplinary management;Traitement des tumeurs épithéliales thymiques: Vers une prise en charge pluridisciplinaire

Revue des Maladies Respiratoires

Volumn 23, Issue 1, 2006, Pages

  Jacot, W ^a   Quantin, X ^a   Pujol, J L ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Carcinoma; Chemotherapy; Multimodal treatment; Radiotherapy; Thymoma

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ERLOTINIB; ETOPOSIDE; GEFITINIB; IFOSFAMIDE; PREDNISONE; SOMATOSTATIN DERIVATIVE; VINCRISTINE; CETUXIMAB; EPIDERMAL GROWTH FACTOR; OCTREOTIDE;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG EFFICACY; EPITHELIUM TUMOR; HUMAN; MEDICAL RESEARCH; METASTASIS; OUTCOME ASSESSMENT; PARANEOPLASTIC SYNDROME; PROGNOSIS; REVIEW; THYMOMA; TREATMENT OUTCOME; CANCER CONTROL; CANCER DIAGNOSIS; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; MULTIMODALITY CANCER THERAPY; PATHOLOGICAL ANATOMY; TUMOR CLASSIFICATION; TUMOR LOCALIZATION;

EID: 33645722170     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0761-8425(06)73415-5     Document Type: Article

References (108)

1. Masaoka A, Monden Y, Nakahara K, Tanioka T : Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981 ; 48 : 2485-92.
2. Curran WJ Jr, Kornstein MJ, Brooks JJ, Turrisi AT 3rd : Invasive thymoma: The role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 1988 ; 6 : 1722-7.
3. Dziuba SJ, Curran WJ Jr : The radio therapeutic management of invasive thymomas. Chest Surg Clin N Am 2001 ; 11 : 457-66.
4. Hejna M, Haberl I, Raderer M : Nonsurgical management of malignant thymoma. Cancer 1999 ; 85 : 1871-84.
5. Ruffie P, Gory-Delabaere G, Fervers B, Lehmann M, Regnard JF, Resbeut M : Standards, options et recommandations pour la prise en charge des patients atteints de tumeurs épithéliales du thymus. Groupe de travail SOR. Bull Cancer 1999 ; 86 : 365-84.
6. Wang LS, Huang MH, Lin TS, Huang BS, Chien KY : Malignant thymoma. Cancer 1992 ; 70 : 443-50.
7. Eng TY, Fuller CD, Jagirdar J, Bains Y, Thomas CR Jr : Thymic carcinoma: State of the art review. Int J Radiat Oncol Biol Phys 2004 ; 59 : 654-64.
8. Thomas CR, Wright CD, Loehrer PJ : Thymoma: State of the art. J Clin Oncol 1999 ; 17 : 2280-9.
9. Levasseur P, Menestrier M, Gaud C, Dartevelle P, Julia P, Rojas-Miranda A, Navajas M, Le Brigand H, Merlier M : Thymomes et maladies associées. À propos de 255 thymomes opérés. Rev Mal Respir 1988 ; 5 : 173-8.
10. Lewis JE, Wick MR, Scheithauer BW, Bernatz PE, Taylor WF : Thymoma. A clinicopathologic review. Cancer 1987 ; 60 : 2727-43.
11. Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E : Thymoma: Results of 241 operated cases. Ann Thorac Surg 1991 ; 51 : 152-6.
12. Murakawa T, Nakajima J, Kohno T, Tanaka M, Matsumoto J, Takeuchi E, Takamoto S : Results from surgical treatment for thymoma. 43 years of experience. Jpn J Thorac Cardiovasc Surg 2000 ; 48 : 89-95.
13. Negron-Soto JM, Cascade PN : Squamous cell carcinoma of the thymus with paraneoplastic hypercalcemia. Clin Imaging 1995 ; 19 : 122-4.
14. Suzuki K, Tanaka H, Shibusa T, Shibuya Y, Inuzuka M, Fujishima T, Abe S : Parathyroid-hormone-related-protein-producing thymic carcinoma presenting as a giant extrathoracic mass. Respiration 1998 ; 65 : 83-5.
15. Evoli A, Lo Monaco M, Marra R, Lino MM, Batocchi AP, Tonali PA : Multiple paraneoplastic diseases associated with thymoma. Neuromuscul Disord 1999 ; 9 : 601-3.
16. Jacot W, Quantin X, Valette S, Khial F, Pujol JL : Multimodality treatment program in invasive thymic epithelial tumor. Am J Clin Oncol 2005 ; 28 : 5-7.
17. Jung KJ, Lee KS, Han J, Kim J, Kim TS, Kim EA : Malignant thymic epithelial tumors: Ct-pathologic correlation. AJR Am J Roentgenol 2001 ; 176 : 433-9.
18. Lee JD, Choe KO, Kim SJ, Kim GE, Im JG, Lee JT : Ct findings in primary thymic carcinoma. J Comput Assist Tomogr 1991 ; 15 : 429-33.
19. Dahan M, Gaillard J, Mary H, Renella-Coll J, Berjaud J : Survie à long terme des thymomes lympho-épithéliaux traités chirurgicalement. Rev Mal Respir 1988 ; 5 : 159-65.
20. Cowen D, Richaud P, Mornex F, Bachelot T, Jung GM, Mirabel X, Marchal C, Lagrange JL, Rambert P, Chaplain G, Nguyen TD, Gastaut JA, Resbeut M : Thymoma: Results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature. Fnclcc trialists. Federation nationale des centres de lutte contre le cancer. Radiother Oncol 1995 ; 34 : 9-16.
21. Kondo K, Monden Y : Therapy for thymic epithelial tumors: A clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003 ; 76 : 878-84 ; discussion 84-5.
22. Chen G, Marx A, Wen-Hu C, Yong J, Puppe B, Stroebel P, Mueller-Hermelink HK : New who histologic classification predicts prognosis of thymic epithelial tumors: A clinicopathologic study of 200 thymoma cases from china. Cancer 2002 ; 95 : 420-9.
23. Quintanilla-Martinez L, Wilkins EW Jr, Choi N, Efird J, Hug E, Harris NL : Thymoma. Histologic subclassification is an independent prognostic factor. Cancer 1994 ; 74 : 606-17.
24. Verley JM, Hollmann KH. Thymoma : A comparative study of clinical stages, histologic features, and survival in 200 cases. Cancer 1985 ; 55 : 1074-86.
25. Marino M, Muller-Hermelink HK : Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch A Pathol Anat Htstopathol 1985 ; 407 : 119-49.
26. Muller-Hermelink HK, Marino M, Palestro G : Pathology of thymic epithelial tumors. Curr Top Pathol 1986 ; 75 : 207-68.
27. Muller-Hermelink HK, Marino M, Palestro G, Schumacher U, Kirchner T : Immunohistological evidences of cortical and medullary differentiation in thymoma. Virchows Arch A Pathol Anat Histopathol 1985 ; 408 : 143-61.
28. Muller-Hermelink HK, Wilisch A, Schultz A, Marx A : Characterization of the human thymic microenvironment: Lymphoepithelial interaction in normal thymus and thymoma. Arch Histol Cytol 1997 ; 60 : 9-28.
29. Schneider PM, Fellbaum C, Fink U, Bollschweiler E, Prauer HW : Prognostic importance of histomorphologic subclassification for epithelial thymic tumors. Ann Surg Oncol 1997 ; 4 : 46-56.
30. Lardinois D, Rechsteiner R, Lang RH, Gugger M, Betticher D, Von Briel C, Krueger T, Ris HB : Prognostic relevance of masaoka and muller-hermelink classification in patients with thymic tumors. Ann Thorac Surg 2000 ; 69 : 1550-5.
31. Gawrychowski J, Rokicki M, Gabriel A, Lackowska B, Czyzewski D : Thymoma - the usefulness of some prognostic factors for diagnosis and surgical treatment. Eur J Surg Oncol 2000 ; 26 : 203-8.
32. Blumberg D, Port JL, Weksler B, Delgado R, Rosai J, Bains MS, Ginsberg RJ, Martini N, Mccormack PM, Rusch V, Burt ME : Thymoma: A multivariate analysis of factors predicting survival. Ann Thorac Surg 1995 ; 60 : 908-13.
33. Pescarmona E, Rendina EA, Venuta F, D'arcangelo E, Pagani M, Ricci C, Ruco LP, Baroni CD : Analysis of prognostic factors and clinicopathological staging of thymoma. Ann Thorac Surg 1990 ; 50 : 534-8.
34. Rosai J, Sobin L : Histological typing of tumours of the thymus. In: International histological classification of tumours. Springer, Berlin: 1999.
35. Okumura M, Ohta M, Tateyama H, Nakagawa K, Matsumura A, Maeda H, Tada H, Eimoto T, Matsuda H, Masaoka A : The world health organization histologic classification system reflects the oncologic behavior of thymoma: A clinical study of 273 patients. Cancer 2002 ; 94 : 624-32.
36. Okumura M, Miyoshi S, Fujii Y, Takeuchi Y, Shiono H, Inoue M, Fukuhara K, Kadota Y, Tateyama H, Eimoto T, Matsuda H : Clinical and functional significance of who classification on human thymic epithelial neoplasms: A study of 146 consecutive tumors. Am J Surg Pathol 2001 ; 25 : 103-10.
37. Kondo K, Yoshizawa K, Tsuyuguchi M, Kimura S, Sumitomo M, Morita J, Miyoshi T, Sakiyama S, Mukai K, Monden Y : Who histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg 2004 ; 77 : 1183-8.
38. Okumura M, Miyoshi S, Takeuchi Y, Yoon HE, Minami M, Takeda SI, Fujii Y, Nakahara K, Matsuda H : Results of surgical treatment of thymomas with special reference to the involved organs. J Thorac Cardiovasc Surg 1999 ; 117 : 605-13.
39. Ogawa K, Toita T, Kakinohana Y, Kamata M, Koja K, Genga K : Postoperative radiation therapy for completely resected invasive thymoma: Prognostic value of pleural invasion for intrathoracic control. Jpn J Clin Oncol 1999 ; 29 : 474-8.
40. Batata MA, Martini N, Huvos AG, Aguilar RI, Beattie EJ Jr : Thymomas: Clinicopathologic features, therapy, and prognosis. Cancer 1974 ; 34 : 389-96.
41. Salyer WR, Eggleston JC : Thymoma: A clinical and pathological study of 65 cases. Cancer 1976 ; 37 : 229-49.
42. Mccart JA, Gaspar L, Inculet R, Casson AG : Predictors of survival following surgical resection of thymoma. J Surg Oncol 1993 ; 54 : 233-8.
43. Sonobe M, Nakagawa M, Ichinose M, Ikegami N, Nagasawa M, Shindo T : Thymoma. Analysis of prognostic factors. Jpn J Thorac Cardiovasc Surg 2001 ; 49 : 35-41.
44. Sugiura H, Morikawa T, Ito K, Ono K, Okushiba S, Satoshi K, Katoh H : Long-term results of surgical treatment for invasive thymoma. Anticancer Res 1999 ; 19 : 1433-7.
45. Levasseur P, Dahan M, Rojas-Miranda A, Dartevelle P, Regnard JF, Verley JM, Merlier M : Results and prognostic factors in surgically treated thymoma. Apropos of a series of 194 cases. Rev Pneumol Clin 1984 ; 40 : 279-84.
46. Kondo K, Monden Y : Thymoma and myasthenia gravis: A clinical study of 1,089 patients from Japan. Ann Thorac Surg 2005 ; 79 : 219-24.
47. Matsushima S, Yamamoto H, Egami K, Suzuki S, Tanaka S : Evaluation of the prognostic factors after thymoma resection. Int Surg 2001 ; 86 : 103-6.
48. Ribet M, Voisin C, Gosselin B, Pruvot Fr, Ramon P, Wallaert B, Dambron P : Thymome lympho-épithélial. Étude anatomo-clinique et thérapeutique de 113 cas. Rev Mal Respir 1988 ; 5 : 53-60.
49. Pan CC, Chen PC, Wang LS, Chi KH, Chiang H : Thymoma is associated with an increased risk of second malignancy. Cancer 2001 ; 92 : 2406-11.
50. Blumberg D, Burt ME, Bains MS, Downey RJ, Martini N, Rusch V, Ginsberg RJ : Thymic carcinoma: Current staging does not predict prognosis. J Thorac Cardiovasc Surg 1998 ; 115 : 303-8 ; discussion 08-9.
51. Hsu CP, Chen CY, Chen CL, Lin CT, Hsu NY, Wang JH, Wang PY : Thymic carcinoma. Ten years' experience in twenty patients. J Thorac Cardiovasc Surg 1994 ; 107 : 615-20.
52. Suster S, Rosai J : Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer 1991 ; 67 : 1025-32.
53. Chang HK, Wang CH, Liaw CC, Ng KT, Chang JP, Chen MS, Kuo TT, Lai GM : Prognosis of thymic carcinoma: Analysis of 16 cases. J Formos Med Assoc 1992 ; 91 : 764-9.
54. Suster S, Moran CA : Primary thymic epithelial neoplasms: Spectrum of differentiation and histological features. Semin Diagn Pathol 1999 ; 16 : 2-17.
55. Ogawa K, Toita T, Uno T, Fuwa N, Kakinohana Y, Kamata M, Koja K, Kinjo T, Adachi G, Murayama S : Treatment and prognosis of thymic carcinoma: A retrospective analysis of 40 cases. Cancer 2002 ; 94 : 3115-9.
56. Takeda S, Sawabata N, Inoue M, Koma M, Maeda H, Hirano H : Thymic carcinoma. Clinical institutional experience with 15 patients. Eur J Cardiothorac Surg 2004 ; 26 : 401-6.
57. Fechner RE : Recurrence of noninvasive thymomas. Report of four cases and review of literature. Cancer 1969 ; 23 : 1423-7.
58. Kirschner PA : Reoperation for thymoma: Report of 23 cases. Ann Thorac Surg 1990 ; 49 : 550-4.
59. Roviaro G, Rebuffat C, Varoli F, Vergani C, Maciocco M, Scalambra SM : Videothoracoscopic excision of mediastinal masses: Indications and technique. Ann Thorac Surg 1994 ; 58 : 1679-83.
60. Ohta M, Hirabayasi H, Okumura M, Minami M, Matsuda H : Thoracoscopic thymectomy using anterior chest wall lifting method. Ann Thorac Surg 2003 ; 76 : 1310-1.
61. Weissberg D, Cohen AJ, Hayat H, Schachner A : Malignant thymoma invading pulmonary artery. Changing treatment options. Ann Ital Chir 2002 ; 73 : 119-22.
62. Yagi K, Hirata T, Fukuse T, Yokomise H, Inui K, Ike O, Mizuno H, Aoki M, Hitomi S, Wada H : Surgical treatment for invasive thymoma, especially when the superior vena cava is invaded. Ann Thorac Surg 1996 ; 61 : 521-4.
63. Fujino S, Tezuka N, Watarida S, Katsuyama K, Inoue S, Mori A : Reconstruction of the aortic arch in invasive thymoma under retrograde cerebral perfusion. Ann Thorac Surg 1998 ; 66 : 263-4.
64. Regnard JF, Zinzindohoue F, Magdeleinat P, Guibert L, Spaggiari L, Levasseur P : Results of re-resection for recurrent thymomas. Ann Thorac Surg 1997 ; 64 : 1593-8.
65. Urgesi A, Monetti U, Rossi G, Ricardi U, Maggi G, Sannazzari GL : Aggressive treatment of intrathoracic recurrences of thymoma. Radiother Oncol 1992 ; 24 : 221-5.
66. Mayer R, Beham-Schmid C, Groell R, Smolle-Juettner FM, Quehenberger F, Stuecklschweiger GF, Prettenhofer U, Stranzl H, Renner H, Hackl A : Radiotherapy for invasive thymoma and thymic carcinoma. Clinicopathological review. Strahlenther Onkol 1999 ; 175 : 271-8.
67. Guerin RA : Radiothérapie des thymomes. Rev Mal Respir 1988 ; 5 : 167-71.
68. Mornex F, Resbeut M, Richaud P, Jung GM, Mirabel X, Marchal C, Lagrange JL, Rambert P, Chaplain G, Nguyen TD : Radiotherapy and chemotherapy for invasive thymomas: A multicentric retrospective review of 90 cases. The fnclcc trialists. Federation nationale des centres de lutte contre le cancer. Int J Radiat Oncol Biol Phys 1995 ; 32 : 651-9.
69. Resbeut M, Mornex F, Richaud P, Bachelot T, Jung G, Mirabel X, Marchal C, Lagrange JP, Rambert P, Chaplain G, N'Guyen TD, Gastoud JA : Radiothérapie des tymomes. Étude de la litterature à propos d'une série rétrospective et multicentrique de 149 cas. Bull Cancer Radiother 1995 ; 82 : 9-19.
70. Pollack A, Komaki R, Cox JD, Ro JY, Oswald MJ, Shin DM, Putnam JB Jr : Thymoma: Treatment and prognosis. Int J Radiat Oncol Biol Phys 1992 ; 23 : 1037-43.
71. Jackson MA, Ball DL : Post-operative radiotherapy in invasive thymoma. Radiother Oncol 1991 ; 21 : 77-82.
72. Nakahara K, Ohno K, Hashimoto J, Maeda H, Miyoshi S, Sakurai M, Monden Y, Kawashima Y : Thymoma: Results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients. J Thorac Cardiovasc Surg 1988 ; 95 : 1041-7.
73. Ciernik IF, Meier U, Lutolf UM : Prognostic factors and outcome of incompletely resected invasive thymoma following radiation therapy. J Clin Oncol 1994 ; 12 : 1484-90.
74. Gripp S, Hilgers K, Wurm R, Schmitt G : Thymoma: Prognostic factors and treatment outcomes. Cancer 1998 ; 83 : 1495-503.
75. Highley MS, Underhill CR, Parnis FX, Karapetis C, Rankin E, Dussek J, Bryant B, Rowland C, Hodson N, Hughes J, Harper PG : Treatment of invasive thymoma with single-agent ifosfamide. J Clin Oncol 1999 ; 17 : 2737-44.
76. Park HS, Shin DM, Lee JS, Komaki R, Pollack A, Putnam JB, Cox JD, Hong WK: Thymoma. A retrospective study of 87 cases. Cancer 1994 ; 73 : 2491-8.
77. Bonomi PD, Finkelstein D, Aisner S, Ettinger D : Est 2582 phase ii trial of cisplatin in metastatic or recurrent thymoma. Am J Clin Oncol 1993 ; 16 : 342-5.
78. Campbell MG, Pollard R, Al-Sarraf M : A complete response in metastatic malignant thymoma to cis-platinum, doxorubicin and cyclophosphamide: A case report. Cancer 1981 ; 48 : 1315-7.
79. Mackintosh JF, Hawson GA, Matar KS, Johnston NG : Initial chemotherapy followed by surgery in malignant thymoma. Aust N Z J Med 1989 ; 19 : 362-4.
80. Loehrer PJ Sr, Perez CA, Roth LM, Greco A, Livingston RB, Einhorn LH : Chemotherapy for advanced thymoma. Preliminary results of an intergroup study. Ann Intern Med 1990 ; 113 : 520-4.
81. Loehrer PJ Sr, Kim K, Aisner SC, Livingston R, Einhorn LH, Johnson D, Blum R : Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: Final results of an intergroup trial. The eastern cooperative oncology group, southwest oncology group, and southeastern cancer study group. J Clin Oncol 1994 ; 12 : 1164-8.
82. Loehrer PJ Sr, Chen M, Kim K, Aisner SC, Einhorn LH, Livingston R, Johnson D : Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: An intergroup trial. J Clin Oncol 1997 ; 15 : 3093-9.
83. Shiu W, Teo P, Wong K : The efficacy of combination cisplatinum, adriamycin and cyclophosphamide in malignant thymoma. Br J Clin Pract 1990 ; 44 : 519-20.
84. Shin DM, Walsh GL, Komaki R, Putnam JB, Nesbitt J, Ro JY, Shin HJ, Ki KH, Wimberly A, Pisters KM, Schrump D, Gregurich MA, Cox JD, Roth JA, Hong WK : A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann Intern Med 1998 ; 129 : 100-4.
85. Fornasiero A, Daniele O, Ghiotto C, Piazza M, Fiore-Donati L, Calabro F, Rea F, Fiorentino MV : Chemotherapy for invasive thymoma. A 13-year experience. Cancer 1991 ; 68 : 30-3.
86. Fornasiero A, Daniele O, Ghiotto C, Sartori F, Rea F, Piazza M, Fiore-Donati L, Morandi P, Aversa SM, Paccagnella A, Pappagallo GL, Fiorentino MV : Chemotherapy of invasive thymoma. J Clin Oncol 1990 ; 8 : 1419-23.
87. Rea F, Sartori F, Loy M, Calabro F, Fornasiero A, Daniele O, Altavilla G : Chemotherapy and operation for invasive thymoma. J Thorac Cardiovasc Surg 1993 ; 106 : 543-9.
88. Uematsu M, Kondo M : A proposal for treatment of invasive thymoma. Cancer 1986 ; 58 : 1979-84.
89. Berruti A, Borasio P, Gerbino A, Gorzegno G, Moschini T, Tampellini M, Ardissone F, Brizzi MP, Dolcetti A, Dogliotti L : Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: A single institution experience. Br J Cancer 1999 ; 81 : 841-5.
90. Yokoi K, Miyazawa N, Mori K, Saito Y, Tominaga K, Imura G, Shimamura K, Hirotani T, Kiso I : Invasive thymoma with intracaval growth into the right atrium. Ann Thorac Surg 1992 ; 53 : 507-9.
91. Macchiarini P, Chella A, Ducci F, Rossi B, Testi C, Bevilacqua G, Angeletti CA : Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer 1991 ; 68 : 706-13.
92. Lucchi M, Mussi A, Basolo F, Ambrogi MC, Fontanini G, Angeletti CA : The multimodality treatment of thymic carcinoma. Eur J Cardiothorac Surg 2001 ; 19 : 566-9.
93. Venuta F, Rendina EA, Longo F, De Giacomo T, Anile M, Mercadante E, Ventura L, Osti MF, Francioni F, Coloni GF : Long-term outcome after multimodality treatment for stage iii thymic tumors. Ann Thorac Surg 2003 ; 76 : 1866-72.
94. Bretti S, Berruti A, Loddo C, Sperone P, Casadio C, Tessa M, Ardissone F, Gorzegno G, Sacco M, Manzin E, Borasio P, Sannazzari GL, Maggi G, Dogliotti L : Multimodal management of stages iii-iva malignant thymoma. Lung Cancer 2004 ; 44 : 69-77.
95. Kim ES, Putnam JB, Komaki R, Walsh GL, Ro JY, Shin HJ, Truong M, Moon H, Swisher SG, Fossella FV, Khuri FR, Hong WK, Shin DM : Phase ii study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: Final report. Lung Cancer 2004 ; 44 : 369-79.
96. Ferone D, Van Hagen MP, Kwekkeboom DJ, Van Koetsveld PM, Mooy DM, Lichtenauer-Kaligis E, Schonbrunn A, Colao A, Lamberts SW, Hofland LJ : Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro. J Clin Endocrinol Metab 2000 ; 85 : 1719-26.
97. Marienhagen J, Schalke B, Aebert H, Held P, Eilles C, Bogdahn U : Somatostatin receptor scintigraphy in thymoma imaging method and clinical application. Pathol Res Pract 1999 ; 195 : 575-81.
98. Lin K, Nguyen BD, Ettinger DS, Chin BB : Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma. Clin Nucl Med 1999 ; 24 : 24-8.
99. Lastoria S, Vergara E, Palmieri G, Acampa W, Varrella P, Caraco C, Bianco RA, Muto P, Salvatore M : In vivo detection of malignant thymic masses by indium-111-dtpa-d-phe1-octreotide scintigraphy. J Nucl Med 1998 ; 39 : 634-9.
100. Palmieri G, Lastoria S, Montella L, Martignetti A, Lombardi G, Salvatore M, Bianco AR : Role of somatostatin analogue-based therapy in unresponsive malignant thymomas. Ann Med 1999 ; 31 Suppl 2 : 80-5.
101. Palmieri G, Montella L, Martignetti A, Muto P, Di Vizio D, De Chiara A, Lastoria S : Somatostatin analogs and prednisone in advanced refractory thymic tumors. Cancer 2002 ; 94 : 1414-20.
102. Loehrer PJ Sr, Wang W, Johnson DH, Aisner SC, Ettinger DS : Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: An eastern cooperative oncology group phase ii trial. J Clin Oncol 2004 ; 22 : 293-9.
103. Hayashi Y, Ishii N, Obayashi C, Jinnai K, Hanioka K, Imai Y, Itoh H : Thymoma: Tumour type related to expression of epidermal growth factor (egf), egf-receptor, p53, v-erb b and ras p21. Virchows Arch 1995 ; 426 : 43-50.
104. Gilhus NE, Jones M, Turley H, Gatter KC, Nagvekar N, Newsom-Davis J, Willcox N : Oncogene proteins and proliferation antigens in thymomas: Increased expression of epidermal growth factor receptor and ki67 antigen. J Clin Pathol 1995 ; 48 : 447-55.
105. Pescarmona E, Pisacane A, Pignatelli E, Baroni CD : Expression of epidermal and nerve growth factor receptors in human thymus and thymomas. Histopathology 1993 ; 23 : 39-44.
106. Henley JD, Koukoulis GK, Loehrer PJ Sr : Epidermal growth factor receptor expression in invasive thymoma. J Cancer Res Clin Oncol 2002 ; 128 : 167-70.
107. Ionescu DN, Sasatomi E, Cieply K, Nola M, Dacic S : Protein expression and gene amplification of epidermal growth factor receptor in thymomas. Cancer 2005 ; 103 : 630-6.
108. Sasaki H, Yukiue H, Sekimura A, Mizuno K, Konishi A, Yano M, Fukai I, Fujii Y : Elevated serum epidermal growth factor receptor level in stage iv thymoma. Surg Today 2004 ; 34 : 477-9.